Literature DB >> 5485121

Reaction of cold agglutinins with I antigen solubilized from human red cells.

W F Rosse, P K Lauf.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5485121

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  7 in total

1.  Immune electron microscopy of cross-reactions between Mycoplasma pneumoniae and human erythrocytes.

Authors:  J E Deas; F A Janney; L T Lee; C Howe
Journal:  Infect Immun       Date:  1979-04       Impact factor: 3.441

2.  Effects of proteolytic enzymes and neuraminidase on the I and i erythrocyte antigen sites. Quantitative and thermodynamic studies.

Authors:  C Doînel; C Ropars; C Salmon
Journal:  Immunology       Date:  1978-04       Impact factor: 7.397

3.  Cold hemagglutinin cross-reactivity with Mycoplasma pneumoniae.

Authors:  F A Janney; L T Lee; C Howe
Journal:  Infect Immun       Date:  1978-10       Impact factor: 3.441

4.  Blood-group-Ii-active gangliosides of human erythrocyte membranes.

Authors:  T Feizi; R A Childs; S I Hakomori; M E Powell
Journal:  Biochem J       Date:  1978-07-01       Impact factor: 3.857

5.  The distribution of blood-group antigens on butanol extraction of human erythrocyte 'ghosts'.

Authors:  D J Anstee; M J Tanner
Journal:  Biochem J       Date:  1974-03       Impact factor: 3.857

6.  Evidence Suggesting Complement Activation and Haemolysis at Core Temperature in Patients with Cold Autoimmune Haemolytic Anaemia.

Authors:  Thilo Bartolmäs; Salih Yürek; Abdelwahab Hassan Ahmed Balola; Beate Mayer; Abdulgabar Salama
Journal:  Transfus Med Hemother       Date:  2015-08-04       Impact factor: 3.747

7.  Lipooligosaccharides (LOS) of Neisseria gonorrhoeae and Neisseria meningitidis have components that are immunochemically similar to precursors of human blood group antigens. Carbohydrate sequence specificity of the mouse monoclonal antibodies that recognize crossreacting antigens on LOS and human erythrocytes.

Authors:  R E Mandrell; J M Griffiss; B A Macher
Journal:  J Exp Med       Date:  1988-07-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.